Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
17.6% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
20
users have followed this narrative
New
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
1.1% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
17
users have liked this narrative
7
users have commented on this narrative
23
users have followed this narrative
9 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
4.7% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
18
users have liked this narrative
7
users have commented on this narrative
20
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
47.4% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
14
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Kawasaki Heavy Industries
AN
AnalystLowTarget
Consensus Narrative from 13 Analysts
Regulation And Global Decarbonization Will Cripple Legacy Demand
Key Takeaways Transition risks from decarbonization and demographic stagnation threaten both revenue growth and legacy product demand, pressuring long-term profitability. High costs, overcapacity, and strong competition may limit margin expansion and weaken returns, despite investments in green technology.
View narrative
JP¥6.78k
FV
39.8% overvalued
intrinsic discount
4.84%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 15 hours ago
author updated this narrative
ARB
AN
AnalystHighTarget
Consensus Narrative from 15 Analysts
Outdoor Demand And Electrification Will Expand Worldwide Markets
Key Takeaways Integration success and rising U.S. sales, plus deeper ties with major automakers, could rapidly transform ARB's revenue mix and global reach. Strong R&D, expansion into electrification, and improving operational bottlenecks support ARB's ability to sustain growth and enhance profit margins worldwide.
View narrative
AU$47.50
FV
14.6% undervalued
intrinsic discount
10.37%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 15 hours ago
author updated this narrative
eMemory Technology
AN
AnalystLowTarget
Consensus Narrative from 6 Analysts
Design Constraints And Competition Will Limit Revenue But Offer Resilience
Key Takeaways Innovation bottlenecks, slow royalty realization, and reliance on a few partners threaten both growth momentum and earnings stability. Emerging alternative technologies and open-source hardware may weaken the long-term value and pricing power of the company's proprietary IP portfolio.
View narrative
NT$2.55k
FV
23.1% undervalued
intrinsic discount
32.05%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 15 hours ago
author updated this narrative
Grifols
AN
AnalystLowTarget
Consensus Narrative from 13 Analysts
Donor Shortages And Gene Therapies Will Weaken Plasma Demand
Key Takeaways Advances in gene therapies and synthetic biologics threaten the relevance and demand for Grifols' plasma-derived products, risking revenue and market share declines. Heightened regulatory scrutiny and donor-related challenges will increase costs, compress margins, and pressure Grifols' long-term profitability.
View narrative
€9.00
FV
36.6% overvalued
intrinsic discount
5.18%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 15 hours ago
author updated this narrative
Securitas
AN
AnalystLowTarget
Consensus Narrative from 11 Analysts
Falling Manned Guarding Revenue Will Press Margins Though Tech Helps
Key Takeaways Structural declines in traditional guarding and slow tech adoption threaten long-term revenue, margin expansion, and recurring earnings growth. Rising labor and regulatory costs, intense competition, and stricter compliance requirements are eroding profitability and market share.
View narrative
SEK 110.00
FV
39.2% overvalued
intrinsic discount
-0.43%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 15 hours ago
author updated this narrative
SBI Holdings
AN
AnalystLowTarget
Consensus Narrative from 5 Analysts
Japan's Aging Population And Tightening Crypto Regulation Will Erode Margins
Key Takeaways Weakening domestic growth and demographic headwinds are likely to erode long-term earnings and weigh on future revenue potential. Intensifying global regulatory pressures and heavy dependence on volatile digital assets threaten profitability and increase operational complexity.
View narrative
JP¥4.73k
FV
38.5% overvalued
intrinsic discount
-3.73%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 15 hours ago
author updated this narrative
Davide Campari-Milano
AN
AnalystLowTarget
Consensus Narrative from 20 Analysts
Falling Alcohol Consumption And Rising Costs Will Undermine Value
Key Takeaways Long-term declines in alcohol consumption and rising compliance costs threaten demand, profitability, and market access for Campari's main brands. Market shifts toward craft spirits and reliance on key brands increase earnings volatility and erode pricing power amid rising costs and supply chain disruptions.
View narrative
€4.27
FV
57.6% overvalued
intrinsic discount
2.10%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 15 hours ago
author updated this narrative
Japan Real Estate Investment
AN
AnalystConsensusTarget
Consensus Narrative from 10 Analysts
Rising Rates Will Depress Office Values In Tokyo
Key Takeaways Reliance on low interest rates, strong occupancy, and premium rents faces risk from demographic decline, office oversupply, and potential rate normalization in Japan. Growth expectations hinge on sustained tourism, business demand, and successful asset upgrades, but aging assets and volatile conditions threaten future earnings and margins.
View narrative
JP¥120.82k
FV
7.6% overvalued
intrinsic discount
-0.93%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 15 hours ago
author updated this narrative
Shiseido Company
AN
AnalystLowTarget
Consensus Narrative from 16 Analysts
Flat Top-Line In Japan And Higher Costs Will Worsen Margins
Key Takeaways Reliance on cost-cutting instead of sales growth threatens profitability amid shrinking consumer base, weak key markets, and unfavorable demographic shifts. Rising regulatory costs, brand weakness abroad, and intensifying competition from agile, digital-first rivals undermine margins and risk long-term market share erosion.
View narrative
JP¥2.00k
FV
26.7% overvalued
intrinsic discount
2.35%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 15 hours ago
author updated this narrative
Value any company in seconds
Popular companies